ArticleInternational journal of molecular sciences2022

Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer Liabilities of Use.

Lisa L Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.